CRH and glucocorticoids directly and/or mutually modulate activities of microglia, and activated microglia release pro-inflammatory mediators, which may result in various psychiatric symptoms such as anxiety, fear, and depression beyond the classical understanding of the HPA axis (Figure 1). Here, CRH is linked to depressive disorder.